Ben Lamm, co-founder of Colossal Biosciences, was simply named to the TIME100 Subsequent 2025 record, recognizing his groundbreaking work in de-extinction biotechnology. Whereas Colossal continues making headline, because of breakthroughs like engineered woolly mammoth prototypes and “dire wolf” cubs who not too long ago celebrated their first birthday, Lamm has additionally been quietly engaged on a brand new synthetic intelligence enterprise: Astromech.
In response to latest SEC filings, Astromech has raised $30 million in stealth-mode funding to construct cutting-edge AI instruments in genomics and artificial biology.
TIME100 Recognition: “A Colossal Imaginative and prescient”
The TIME100 Subsequent profile, written by George Church, credit Lamm for assembling a coalition of conservationists, Indigenous leaders, gene therapists, and AI specialists. This group powers Colossal’s mission to make use of historical DNA to assist revive misplaced biodiversity. Their success has sparked international intrigue, with protection in retailers like TIME, The New York Instances, and Wired, and cemented Lamm’s function as a number one biotech innovator.
From Genomes to Generative AI
Astromech’s website stays minimal and mysterious, however its profession postings trace at a daring imaginative and prescient: AI for genomic inference, synthesis design, and ancestral modeling. The corporate is hiring specialists in sequence reconstruction, gene regulation, protein folding, and extra.
The stealth launch aligns with Lamm’s broader imaginative and prescient: making use of computation not solely to know the previous, however to reshape the way forward for life.
Why It Issues for AI and Life Sciences
Astromech’s work sits on the intersection of synthetic intelligence and biotechnology—a convergence of fields more and more seen as the subsequent frontier in precision medication, artificial biology, and evolutionary modeling. Lamm and Church’s earlier work collectively at Colossal has already redefined the sphere of de-extinction; Astromech could now do the identical for AI in life sciences.
Desire a deeper dive into Colossal’s scientific mannequin? Learn their Science web page or discover the Colossal Basis to see how their initiatives help international conservation.
Observe Report of Management
Lamm’s resume spans a number of profitable exits, together with:
- Hypergiant – AI for vital infrastructure (acquired by Trive Capital)
- Conversable – Conversational commerce platform (acquired by LivePerson)
- Chaotic Moon – Artistic tech studio (acquired by Accenture)
His ventures are inclined to skate forward of market tendencies—and infrequently get acquired by main gamers as soon as the world catches up.
What’s Subsequent
With two deeply technical firms now below his management, Lamm is among the many few founders really working on the crossroads of genetic science and synthetic intelligence. His capability to safe main funding whereas managing high-profile, high-risk initiatives units him aside in each biotech and venture-backed tech.
Observe Lamm on X, subscribe to Colossal’s newsroom, or watch Astromech.com as the corporate steadily steps out of stealth.
Have you ever learn?
Least-visited international locations.
Richest NFL Gamers of All Time.
US States Ranked by Life Expectancy.
International locations that Store On-line the Most.
